As of Dec 3, 2024, Quotient's P/S ratio stood at 0, a 0% change from the 0 P/S ratio recorded in the previous year.

The Quotient P/S history

Quotient Aktienanalyse

What does Quotient do?

Quotient Ltd is a biopharmaceutical company headquartered in Eysins, Switzerland. The company was founded in 2007 with the aim of developing innovative technologies in the field of Personalized Medicine. This means that medications and therapies are specifically tailored to the individual needs of patients. Thanks to state-of-the-art production processes, products can be produced quickly and safely. Quotient Ltd has a unique business model based on transfusion technology. This technology allows the company to produce medications quickly and accurately. The different components of the medications are separated and then combined in the required dosage. This means that the medications can be precisely dosed and the risks of side effects minimized. A key focus of Quotient Ltd is the development of therapeutics. Personalized medicine and the fast and safe production of medications are at the center of this area. The transfusion technology enables medications to be produced quickly and flexibly, which is particularly important for rare diseases and personalized therapies. Another important area is the development of diagnostics. These enable diseases to be diagnosed quickly and safely. Based on this diagnosis, suitable therapies are then developed. Quotient Ltd also relies on transfusion technology for this, which enables fast, reliable, and flexible production of diagnostics. In addition to its developed technology and know-how, Quotient Ltd also has its own production facility. Here, all products are produced to the highest standards. The production facility covers an area of approximately 6,000 square meters. The modern facility is equipped with the latest technologies and meets the highest quality standards. Quotient Ltd offers a variety of products, with a special focus on personalized medicine and the fast and safe production of medications and diagnostics. One example is the PDA diagnostic system, which was developed for the fast and accurate diagnosis of autoimmune diseases. The MosaiQ system is another important product that enables fast and reliable production of medications. The success story of Quotient Ltd is closely linked to the development of transfusion technology. The company has succeeded in developing a technology that allows for the fast and safe production of personalized medicine. This technology has made Quotient Ltd a leading company in the field of personalized medicine worldwide. Today, Quotient Ltd employs over 700 people who are constantly working on the further development of personalized medicine and transfusion technology. Quotient ist eines der beliebtesten Unternehmen auf Eulerpool.com.

P/S Details

Decoding Quotient's P/S Ratio

Quotient's Price to Sales (P/S) Ratio is a crucial financial metric that measures the company's market valuation relative to its total sales revenue. It's calculated by dividing the company's market capitalization by its total sales over a specific period. A lower P/S ratio can indicate that the company is undervalued, while a higher ratio may suggest overvaluation.

Year-to-Year Comparison

Comparing Quotient's P/S ratio yearly provides insights into how the market perceives the company’s value relative to its sales. An increasing ratio over time can indicate growing investor confidence, while a decreasing trend might reflect concerns about the company’s revenue generation capabilities or market conditions.

Impact on Investments

The P/S ratio is instrumental for investors evaluating Quotient's stock. It offers insights into the company’s efficiency in generating sales and its market valuation. Investors use this ratio to compare similar companies within the same industry, aiding in selecting stocks that offer the best value for investment.

Interpreting P/S Ratio Fluctuations

Variations in Quotient’s P/S ratio can result from changes in the stock price, sales revenue, or both. Understanding these fluctuations is crucial for investors to evaluate the company’s current valuation and future growth potential, aligning their investment strategies accordingly.

Frequently Asked Questions about Quotient stock

What is the price-to-earnings ratio of Quotient?

The price-earnings ratio of Quotient is currently 0.

How has the price-earnings ratio of Quotient changed compared to last year?

The price-to-earnings ratio of Quotient has increased by 0% fallen (meaning "decreased" or "dropped") compared to last year.

What consequences does a high price-earnings ratio have for investors?

A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.

What does a low price-earnings ratio mean?

A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.

Is the price-earnings ratio of Quotient high compared to other companies?

Yes, the price-to-earnings ratio of Quotient is high compared to other companies.

How does an increase in the price-earnings ratio of Quotient affect the company?

An increase in the price-earnings ratio of Quotient would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.

How does a reduction in the price-to-earnings ratio of Quotient affect the company?

A decrease in the price-earnings ratio of Quotient would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.

What are some factors that influence the price-earnings ratio of Quotient?

Some factors that influence the price-earnings ratio of Quotient are the company's growth, financial position, industry development, and the overall economic situation.

How much dividend does Quotient pay?

Over the past 12 months, Quotient paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Quotient is expected to pay a dividend of 0 USD.

What is the dividend yield of Quotient?

The current dividend yield of Quotient is .

When does Quotient pay dividends?

Quotient pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Quotient?

Quotient paid dividends every year for the past 0 years.

What is the dividend of Quotient?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Quotient located?

Quotient is assigned to the 'Health' sector.

Wann musste ich die Aktien von Quotient kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Quotient from 12/3/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 12/3/2024.

When did Quotient pay the last dividend?

The last dividend was paid out on 12/3/2024.

What was the dividend of Quotient in the year 2023?

In the year 2023, Quotient distributed 0 USD as dividends.

In which currency does Quotient pay out the dividend?

The dividends of Quotient are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Quotient

Our stock analysis for Quotient Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Quotient Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.